Company · CIK 0001520512 · SIC 2834 — Pharmaceutical Preparations
il2m INTERNATIONAL CORP. · ILIM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2015 JForm 4 → | May 13, 7:55 pm EDT | il2m Global Limited.10% Owner | 125,000,000 | — | — | 0 | — | plan? |
| Apr 27, 2015 GForm 4 → | May 14, 2:25 pm EDT | Sarkis Ara TsaoussianPresident/CEO, Director | 15,465,000 | — | — | 1,500,000,000 | — | plan? late |
| Mar 1, 2015 JForm 4 → | Mar 4, 12:01 pm EST | Sarkis Ara TsaoussianPresident/CEO, Director | 1,500,000,000 | $0.0002 | $300,000 | 1,515,465,000 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.